Skip to Main Navigation
Skip to Page Content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Share This:
https://ntp.niehs.nih.gov/go/5213

TDMS Study 05704-03 Pathology Tables


                                     INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)
                                                             RESORCINOL


NTP Experiment-Test: 05704-03                                                                                     Report: PEIRPT03
Study Type: CHRONIC                                                                                               Date: 09/18/94
Route: GAVAGE                                                                                                     Time: 18:48:42




       Facility:  International Research and Development Corp.

       Chemical CAS #:  000108463

       Lock Date:  None

       Cage Range:  All

       Reasons For Removal:    All

       Removal Date Range:     All

       Treatment Groups:       Include All
































a  Number of animals examined microscopically at site and number of animals with lesion

                                                             Page   1

NTP Experiment-Test: 05704-03         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                             RESORCINOL                                        Date: 09/18/94  
Route: GAVAGE                                                                                                     Time: 18:48:42  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS FEMALE                   VEHICLE/     50 MG/KG     100 MG/K     150 MG/K                                  
                                                   CONTROL                   G            G                                         
____________________________________________________________________________________________________________________________________
DISPOSITION SUMMARY                                                                                                                 
  Animals Initially In Study                          60           60           60           60                                     
  Scheduled Sacrifice                                 10           10           10           10                                     
  Early Deaths                                                                                                                      
    Moribund                                          15           11           16           12                                     
    Dead                                               1            5            6           13                                     
    Accident                                                        1                                                               
    Dosing Accident                                                                           1                                     
  Survivors                                                                                                                         
    Terminal Sacrifice                                34           33           27           24                                     
    Dead                                                                         1                                                  
  Animals Examined Microscopically                    58           53           55           57                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ALIMENTARY SYSTEM                                                                                                                  
                                                                                                                                    
   Esophagus                                          (48)         (47)         (46)         (48)                                   
      Abscess                                                       1 (2%)                                                          
   Intestine Large, Cecum                             (50)         (50)         (49)         (46)                                   
      Parasite Metazoan                                             1 (2%)                    1 (2%)                                
   Intestine Large, Colon                             (50)         (50)         (50)         (48)                                   
      Parasite Metazoan                                6 (12%)      4 (8%)       4 (8%)       6 (13%)                               
   Intestine Large, Rectum                            (50)         (50)         (50)         (47)                                   
      Parasite Metazoan                                5 (10%)      4 (8%)                    4 (9%)                                
   Intestine Small, Duodenum                          (50)         (50)         (49)         (48)                                   
      Inflammation, Chronic                                         1 (2%)                                                          
   Intestine Small, Ileum                             (50)         (50)         (49)         (47)                                   
      Parasite Metazoan                                1 (2%)                                                                       
   Liver                                              (51)         (50)         (50)         (51)                                   
      Angiectasis, Focal                               3 (6%)       3 (6%)       5 (10%)      1 (2%)                                
      Basophilic Focus                                 9 (18%)     14 (28%)     11 (22%)      7 (14%)                               
      Basophilic Focus, Multiple                      32 (63%)     27 (54%)     19 (38%)     27 (53%)                               
      Clear Cell Focus                                10 (20%)      5 (10%)      1 (2%)       7 (14%)                               
      Clear Cell Focus, Multiple                       2 (4%)       4 (8%)       3 (6%)       1 (2%)                                
      Congestion, Focal                                1 (2%)       3 (6%)                                                          
      Cytoplasmic Alteration, Focal                                 3 (6%)       1 (2%)       1 (2%)                                
      Fibrosis, Focal                                                            1 (2%)                                             
      Granuloma, Focal                                              1 (2%)                    1 (2%)                                
      Hematocyst                                       1 (2%)                                                                       
      Hematopoietic Cell Proliferation                                                        2 (4%)                                
      Hepatodiaphragmatic Nodule                       4 (8%)       9 (18%)      7 (14%)      7 (14%)                               
      Hepatodiaphragmatic Nodule, Multiple             4 (8%)       2 (4%)       1 (2%)                                             
      Hyperplasia, Focal                               1 (2%)                                                                       
      Inflammation, Chronic, Focal                    32 (63%)     25 (50%)     29 (58%)     24 (47%)                               
      Necrosis, Focal                                  1 (2%)       2 (4%)       1 (2%)       2 (4%)                                
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    2                                                              
NTP Experiment-Test: 05704-03         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                             RESORCINOL                                        Date: 09/18/94  
Route: GAVAGE                                                                                                     Time: 18:48:42  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS FEMALE                   VEHICLE/     50 MG/KG     100 MG/K     150 MG/K                                  
                                                   CONTROL                   G            G                                         
____________________________________________________________________________________________________________________________________
                                                                                                                                    
ALIMENTARY SYSTEM - CONT                                                                                                            
      Pigmentation                                                               1 (2%)                                             
      Bile Duct, Cyst                                               1 (2%)                    1 (2%)                                
      Bile Duct, Hyperplasia                          32 (63%)     23 (46%)     26 (52%)     35 (69%)                               
      Centrilobular, Atrophy, Diffuse                               1 (2%)                                                          
      Centrilobular, Fatty Change                      7 (14%)      8 (16%)      5 (10%)      1 (2%)                                
      Periportal, Fatty Change                                                   1 (2%)                                             
      Serosa, Fibrosis, Focal                          2 (4%)       1 (2%)                                                          
      Serosa, Inflammation, Chronic, Focal                                       1 (2%)                                             
   Mesentery                                          (2)                       (2)          (3)                                    
      Fat, Necrosis                                    2 (100%)                  2 (100%)     2 (67%)                               
   Pancreas                                           (50)         (49)         (50)         (49)                                   
      Atrophy, Focal                                  17 (34%)     15 (31%)     19 (38%)     13 (27%)                               
      Focal Cellular Change                            1 (2%)       1 (2%)                                                          
      Hyperplasia, Focal                               2 (4%)       1 (2%)                    1 (2%)                                
      Inflammation, Chronic, Focal                                               1 (2%)                                             
      Metaplasia, Focal                                             1 (2%)                                                          
      Artery, Inflammation, Chronic, Focal                                       1 (2%)                                             
   Salivary Glands                                    (50)         (50)         (48)         (50)                                   
      Atrophy                                                       3 (6%)       2 (4%)                                             
      Cyst                                                                                    1 (2%)                                
      Inflammation, Chronic                            1 (2%)       1 (2%)                                                          
      Duct, Ectasia, Focal                             1 (2%)                                                                       
   Stomach, Forestomach                               (50)         (50)         (48)         (50)                                   
      Hyperplasia, Diffuse, Squamous                   1 (2%)                    2 (4%)                                             
      Hyperplasia, Focal, Squamous                                  1 (2%)       1 (2%)                                             
      Inflammation, Acute, Diffuse                                                            1 (2%)                                
      Inflammation, Chronic, Diffuse                   1 (2%)                    2 (4%)                                             
      Inflammation, Chronic, Focal                                  3 (6%)       1 (2%)                                             
      Mineralization                                                             1 (2%)       2 (4%)                                
      Ulcer                                            1 (2%)       1 (2%)       2 (4%)                                             
   Stomach, Glandular                                 (50)         (50)         (50)         (50)                                   
      Erosion                                          1 (2%)       1 (2%)       2 (4%)       1 (2%)                                
      Inflammation, Acute, Focal                                                              1 (2%)                                
      Mineralization                                                             1 (2%)       2 (4%)                                
      Ulcer                                                         2 (4%)       1 (2%)                                             
   Tongue                                                          (1)                                                              
      Epithelium, Hyperplasia, Focal                                1 (100%)                                                        
   Tooth                                              (1)          (3)                       (1)                                    
      Inflammation, Chronic                                         2 (67%)                   1 (100%)                              
      Gingiva, Foreign Body                            1 (100%)                                                                     
      Gingiva, Hyperplasia, Focal, Squamous            1 (100%)                                                                     
      Gingiva, Inflammation, Chronic, Focal            1 (100%)                                                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    3                                                              
NTP Experiment-Test: 05704-03         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                             RESORCINOL                                        Date: 09/18/94  
Route: GAVAGE                                                                                                     Time: 18:48:42  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS FEMALE                   VEHICLE/     50 MG/KG     100 MG/K     150 MG/K                                  
                                                   CONTROL                   G            G                                         
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 CARDIOVASCULAR SYSTEM                                                                                                              
                                                                                                                                    
   Heart                                              (50)         (50)         (50)         (50)                                   
      Inflammation, Chronic, Focal                    28 (56%)     28 (56%)     29 (58%)     22 (44%)                               
      Mineralization, Multifocal                                                 1 (2%)       1 (2%)                                
      Thrombosis                                                    1 (2%)                                                          
      Artery, Hyperplasia, Focal                                                              1 (2%)                                
      Artery, Mineralization                                                                  1 (2%)                                
      Atrium, Thrombosis                                                         1 (2%)                                             
      Endocardium, Hemorrhage, Focal                   1 (2%)                                                                       
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ENDOCRINE SYSTEM                                                                                                                   
                                                                                                                                    
   Adrenal Gland, Cortex                              (50)         (50)         (50)         (50)                                   
      Angiectasis                                      4 (8%)       3 (6%)       2 (4%)                                             
      Atrophy, Diffuse                                                           1 (2%)                                             
      Congestion                                                                 1 (2%)                                             
      Cyst                                             1 (2%)                                                                       
      Cytoplasmic Alteration, Focal                    2 (4%)       1 (2%)       1 (2%)                                             
      Degeneration, Ballooning, Focal                  1 (2%)                                                                       
      Degeneration, Diffuse, Fatty                                                            1 (2%)                                
      Degeneration, Fatty, Focal                      17 (34%)     15 (30%)     22 (44%)     10 (20%)                               
      Hematocyst                                       2 (4%)                                                                       
      Hemorrhage, Focal                                             1 (2%)                                                          
      Hyperplasia, Focal                              14 (28%)     13 (26%)      7 (14%)      7 (14%)                               
      Hypertrophy, Focal                               2 (4%)                    3 (6%)       2 (4%)                                
      Mineralization, Focal                                         1 (2%)                                                          
      Pigmentation                                                               1 (2%)                                             
   Adrenal Gland, Medulla                             (48)         (49)         (45)         (48)                                   
      Angiectasis                                                                             1 (2%)                                
      Hematocyst                                                                 1 (2%)                                             
      Hyperplasia                                     14 (29%)     15 (31%)     14 (31%)      8 (17%)                               
   Islets, Pancreatic                                 (50)         (47)         (49)         (49)                                   
      Hyperplasia, Focal                                            2 (4%)                    2 (4%)                                
   Parathyroid Gland                                  (46)         (39)         (42)         (41)                                   
      Hyperplasia, Diffuse                                                       1 (2%)                                             
      Hyperplasia, Focal                                            1 (3%)                                                          
      Hypoplasia, Diffuse                                           1 (3%)                                                          
   Pituitary Gland                                    (53)         (51)         (52)         (52)                                   
      Amyloid Deposition                               1 (2%)                                                                       
      Angiectasis                                     10 (19%)      6 (12%)      7 (13%)      7 (13%)                               
      Cyst                                            17 (32%)     23 (45%)     21 (40%)     19 (37%)                               
      Cyst, Multiple                                   4 (8%)       3 (6%)       9 (17%)      2 (4%)                                
      Ectasia                                          1 (2%)                                                                       
      Pigmentation, Focal                                           1 (2%)                                                          
      Pars Distalis, Angiectasis                       1 (2%)                                 1 (2%)                                
      Pars Distalis, Angiectasis, Focal                             3 (6%)       1 (2%)                                             
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    4                                                              
NTP Experiment-Test: 05704-03         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                             RESORCINOL                                        Date: 09/18/94  
Route: GAVAGE                                                                                                     Time: 18:48:42  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS FEMALE                   VEHICLE/     50 MG/KG     100 MG/K     150 MG/K                                  
                                                   CONTROL                   G            G                                         
____________________________________________________________________________________________________________________________________
                                                                                                                                    
ENDOCRINE SYSTEM - CONT                                                                                                             
      Pars Distalis, Hyperplasia, Focal                8 (15%)      8 (16%)     11 (21%)      5 (10%)                               
      Pars Distalis, Hyperplasia, Multifocal           1 (2%)                                                                       
      Pars Distalis, Hypoplasia                                                  1 (2%)                                             
      Pars Distalis, Metaplasia, Focal, Osseous                     1 (2%)                                                          
      Pars Nervosa, Metaplasia, Focal, Osseous                                   1 (2%)                                             
   Thyroid Gland                                      (50)         (49)         (50)         (50)                                   
      Hemorrhage, Multifocal                                        1 (2%)                                                          
      C-Cell, Hyperplasia, Focal                       9 (18%)     12 (24%)     10 (20%)      1 (2%)                                
      Follicular Cell, Metaplasia, Focal, Squamous     1 (2%)                                                                       
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENERAL BODY SYSTEM                                                                                                                
                                                                                                                                    
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENITAL SYSTEM                                                                                                                     
                                                                                                                                    
   Clitoral Gland                                     (46)         (41)         (42)         (49)                                   
      Atrophy                                                       1 (2%)                    1 (2%)                                
      Concretion                                                                 1 (2%)                                             
      Dilatation                                       2 (4%)                    1 (2%)       3 (6%)                                
      Hyperplasia, Focal                               3 (7%)       3 (7%)       1 (2%)       3 (6%)                                
      Inflammation, Chronic, Focal                     5 (11%)      4 (10%)      1 (2%)       2 (4%)                                
      Inflammation, Suppurative                        1 (2%)                                                                       
   Ovary                                              (52)         (50)         (49)         (51)                                   
      Congestion                                                    2 (4%)                                                          
      Cyst                                             7 (13%)      5 (10%)      4 (8%)       2 (4%)                                
      Granuloma, Focal                                              1 (2%)                                                          
      Corpus Luteum, Necrosis                          1 (2%)                                                                       
      Periovarian Tissue, Necrosis, Focal              1 (2%)                                                                       
   Uterus                                             (51)         (52)         (52)         (52)                                   
      Dilatation                                                    2 (4%)       1 (2%)       1 (2%)                                
      Fibrosis                                                      2 (4%)                                                          
      Hydrometra                                                    1 (2%)                    1 (2%)                                
      Hyperplasia, Chronic, Cystic                     4 (8%)                    1 (2%)       2 (4%)                                
      Hyperplasia, Cystic                                                        1 (2%)                                             
      Inflammation, Suppurative                                                               1 (2%)                                
      Artery, Mineralization, Focal                                                           1 (2%)                                
      Cervix, Fibrosis                                 1 (2%)       1 (2%)                    1 (2%)                                
      Lumen, Hemorrhage                                             1 (2%)       1 (2%)                                             
      Serosa, Necrosis                                 1 (2%)                                                                       
   Vagina                                             (2)                       (1)                                                 
      Inflammation, Subacute                                                     1 (100%)                                           
      Necrosis, Acute, Diffuse                                                   1 (100%)                                           
      Prolapse                                                                   1 (100%)                                           
____________________________________________________________________________________________________________________________________
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    5                                                              
NTP Experiment-Test: 05704-03         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                             RESORCINOL                                        Date: 09/18/94  
Route: GAVAGE                                                                                                     Time: 18:48:42  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS FEMALE                   VEHICLE/     50 MG/KG     100 MG/K     150 MG/K                                  
                                                   CONTROL                   G            G                                         
____________________________________________________________________________________________________________________________________
                                                                                                                                    
                                                                                                                                    
 HEMATOPOIETIC SYSTEM                                                                                                               
                                                                                                                                    
   Bone Marrow                                        (50)         (50)         (50)         (48)                                   
      Myelofibrosis, Focal                             1 (2%)       1 (2%)       3 (6%)                                             
      Erythroid Cell, Proliferation                    1 (2%)                    3 (6%)       1 (2%)                                
      Myeloid Cell, Proliferation                      1 (2%)                    1 (2%)       2 (4%)                                
   Lymph Node                                         (50)         (50)         (50)         (50)                                   
      Congestion                                                                              1 (2%)                                
      Axillary, Hyperplasia, Plasma Cell                                                      1 (2%)                                
      Axillary, Infiltration Cellular, Histiocyte      1 (2%)                    1 (2%)                                             
      Iliac, Ectasia                                                1 (2%)                                                          
      Iliac, Hyperplasia, Plasma Cell                  1 (2%)                                                                       
      Iliac, Infiltration Cellular, Histiocyte                      1 (2%)                                                          
      Inguinal, Ectasia                                                          2 (4%)                                             
      Inguinal, Hyperplasia, Lymphoid                                            1 (2%)                                             
      Inguinal, Hyperplasia, Plasma Cell                                         1 (2%)                                             
      Mandibular, Congestion                           1 (2%)       1 (2%)                    1 (2%)                                
      Mandibular, Hyperplasia, Plasma Cell             2 (4%)       1 (2%)       2 (4%)       2 (4%)                                
      Mediastinal, Congestion                                       2 (4%)                    1 (2%)                                
      Mediastinal, Hemorrhage                          1 (2%)                                 2 (4%)                                
      Mediastinal, Hyperplasia, Lymphoid                            1 (2%)                                                          
      Mediastinal, Hyperplasia, Plasma Cell                         1 (2%)                    1 (2%)                                
      Mediastinal, Inflammation, Suppurative           1 (2%)                                                                       
      Mediastinal, Pigmentation                                                  1 (2%)                                             
   Lymph Node, Mesenteric                             (50)         (50)         (48)         (50)                                   
      Congestion                                       1 (2%)       1 (2%)                                                          
      Fibrosis, Focal                                               1 (2%)                                                          
      Granuloma, Focal                                                                        1 (2%)                                
      Hemorrhage                                       1 (2%)                    1 (2%)                                             
   Spleen                                             (50)         (50)         (51)         (50)                                   
      Angiectasis                                      1 (2%)                                                                       
      Congestion, Focal                                                          1 (2%)       2 (4%)                                
      Fibrosis, Focal                                                            2 (4%)                                             
      Hematocyst                                                                              1 (2%)                                
      Hematopoietic Cell Proliferation                 4 (8%)       2 (4%)       3 (6%)       5 (10%)                               
      Hematopoietic Cell Proliferation Granulocytic                                           1 (2%)                                
      Hyperplasia, Lymphoid                            1 (2%)                                                                       
      Necrosis, Acute, Focal                                                                  1 (2%)                                
      Thrombosis                                                                 1 (2%)                                             
      Capsule, Fibrosis                                1 (2%)                                 1 (2%)                                
   Thymus                                             (47)         (45)         (48)         (48)                                   
      Cyst                                             1 (2%)       1 (2%)       3 (6%)       2 (4%)                                
      Cyst, Multiple                                                2 (4%)                                                          
      Hemorrhage                                       1 (2%)       1 (2%)                    5 (10%)                               
      Epithelial Cell, Hyperplasia                                                            1 (2%)                                
      Mediastinum, Inflammation, Acute                              1 (2%)                                                          
____________________________________________________________________________________________________________________________________
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    6                                                              
NTP Experiment-Test: 05704-03         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                             RESORCINOL                                        Date: 09/18/94  
Route: GAVAGE                                                                                                     Time: 18:48:42  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS FEMALE                   VEHICLE/     50 MG/KG     100 MG/K     150 MG/K                                  
                                                   CONTROL                   G            G                                         
____________________________________________________________________________________________________________________________________
                                                                                                                                    
                                                                                                                                    
 INTEGUMENTARY SYSTEM                                                                                                               
                                                                                                                                    
   Mammary Gland                                      (51)         (50)         (50)         (50)                                   
      Galactocele                                      1 (2%)       1 (2%)                                                          
      Galactocele, Multiple                                         1 (2%)                                                          
      Hyperplasia, Cystic, Glandular                                             2 (4%)                                             
      Mineralization                                                             1 (2%)                                             
   Skin                                               (50)         (50)         (51)         (50)                                   
      Developmental Malformation                                                 1 (2%)                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 MUSCULOSKELETAL SYSTEM                                                                                                             
                                                                                                                                    
   Bone                                               (50)         (50)         (50)         (49)                                   
      Cranium, Hyperostosis                                         1 (2%)                                                          
      Femur, Fibrous Osteodystrophy                                              1 (2%)       1 (2%)                                
      Femur, Hyperostosis                                           3 (6%)       1 (2%)                                             
      Femur, Osteopetrosis                             1 (2%)       2 (4%)                    2 (4%)                                
      Maxilla, Hyperostosis                                                      1 (2%)                                             
      Turbinate, Hyperostosis                                       2 (4%)       1 (2%)                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 NERVOUS SYSTEM                                                                                                                     
                                                                                                                                    
   Brain                                              (50)         (50)         (50)         (49)                                   
      Hemorrhage, Focal                                2 (4%)       3 (6%)                    1 (2%)                                
   Spinal Cord                                                                               (1)                                    
      Hemorrhage, Focal                                                                       1 (100%)                              
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 RESPIRATORY SYSTEM                                                                                                                 
                                                                                                                                    
   Lung                                               (50)         (50)         (51)         (50)                                   
      Congestion                                       7 (14%)     12 (24%)     11 (22%)      8 (16%)                               
      Congestion, Diffuse                                                        1 (2%)                                             
      Emphysema, Focal                                              1 (2%)                    1 (2%)                                
      Foreign Body                                     3 (6%)                    1 (2%)                                             
      Granuloma, Focal                                                           3 (6%)                                             
      Hemorrhage, Focal                                1 (2%)       1 (2%)       2 (4%)       2 (4%)                                
      Hyperplasia, Focal                               2 (4%)       4 (8%)       5 (10%)      2 (4%)                                
      Inflammation, Acute, Focal                       1 (2%)                                 1 (2%)                                
      Inflammation, Chronic, Diffuse                                             1 (2%)                                             
      Inflammation, Chronic, Focal                     6 (12%)      3 (6%)       1 (2%)       5 (10%)                               
      Metaplasia, Focal, Osseous                                                 1 (2%)                                             
      Interstitium, Mineralization, Diffuse                                      1 (2%)                                             
      Interstitium, Mineralization, Focal                                                     1 (2%)                                
   Nose                                               (49)         (50)         (50)         (50)                                   
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    7                                                              
NTP Experiment-Test: 05704-03         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                             RESORCINOL                                        Date: 09/18/94  
Route: GAVAGE                                                                                                     Time: 18:48:42  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS FEMALE                   VEHICLE/     50 MG/KG     100 MG/K     150 MG/K                                  
                                                   CONTROL                   G            G                                         
____________________________________________________________________________________________________________________________________
                                                                                                                                    
RESPIRATORY SYSTEM - CONT                                                                                                           
      Foreign Body                                     1 (2%)       1 (2%)       2 (4%)       4 (8%)                                
      Fungus                                           1 (2%)       2 (4%)       1 (2%)       3 (6%)                                
      Inflammation, Acute                                                        1 (2%)                                             
      Inflammation, Acute, Focal                                                 2 (4%)                                             
      Inflammation, Chronic, Focal                     2 (4%)       1 (2%)       1 (2%)       1 (2%)                                
      Inflammation, Focal, Suppurative                 1 (2%)       2 (4%)                    6 (12%)                               
      Metaplasia, Squamous                                                       1 (2%)                                             
      Nasolacrimal Duct, Inflammation, Chronic         1 (2%)                    1 (2%)                                             
      Nasolacrimal Duct, Inflammation, Suppurative     1 (2%)                                                                       
   Trachea                                            (50)         (50)         (50)         (50)                                   
      Mineralization, Focal                                                                   1 (2%)                                
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 SPECIAL SENSES SYSTEM                                                                                                              
                                                                                                                                    
   Eye                                                (3)          (7)          (1)          (3)                                    
      Atrophy                                                       2 (29%)                                                         
      Cataract                                         1 (33%)                                                                      
      Synechia                                                      2 (29%)                                                         
      Lens, Cataract                                   1 (33%)      5 (71%)      1 (100%)     2 (67%)                               
      Retina, Degeneration                                          5 (71%)                   1 (33%)                               
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 URINARY SYSTEM                                                                                                                     
                                                                                                                                    
   Kidney                                             (50)         (50)         (50)         (50)                                   
      Congestion                                                    2 (4%)       2 (4%)       3 (6%)                                
      Cyst                                             2 (4%)       1 (2%)       2 (4%)       1 (2%)                                
      Degeneration, Diffuse, Hyaline                                             1 (2%)                                             
      Glomerulosclerosis                               1 (2%)                                                                       
      Hemorrhage, Focal                                             1 (2%)                                                          
      Hydronephrosis                                                                          1 (2%)                                
      Hyperplasia                                      1 (2%)                                                                       
      Mineralization                                                             1 (2%)       2 (4%)                                
      Nephropathy, Chronic                            47 (94%)     47 (94%)     48 (96%)     43 (86%)                               
      Pigmentation                                     4 (8%)       2 (4%)       4 (8%)       3 (6%)                                
      Pelvis, Hemorrhage                               1 (2%)                                                                       
      Pelvis, Hyperplasia                              1 (2%)                                                                       
      Pelvis, Inflammation, Chronic                    2 (4%)                                                                       
      Pelvis, Mineralization                                                     1 (2%)                                             
   Urinary Bladder                                    (50)         (49)         (48)         (49)                                   
      Inflammation, Chronic, Focal                                               1 (2%)                                             
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    8                                                              
                             ------------------------------------------------------------                                           
                             ----------              END OF REPORT             ----------                                           
                             ------------------------------------------------------------